Boehringer Ingelheim

Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. For more than 130 years, the family-owned company has developed new medicines for people and animals. Boehringer Ingelheim’s nearly 50,000 employees work to implement the company’s mission to spread value through innovation in three core areas: human medicine, veterinary medicine, and biopharmaceutical contract-based production. The company demonstrates its social responsibility by actively participating in the “Making More Health” initiative and prioritizing environmental protection and sustainability in all levels of operation. In Norway, Boehringer Ingelheim employs 71 people. In 2018, Boehringer Ingelheim’s Norwegian Branch achieved a total net sales revenue of NOK 423,000,000.